BioMerieux Inventory 2017-2023 | BMXMF

BioMerieux inventory from 2017 to 2023. Inventory can be defined as the total value of inventories in all stages of completion.
  • BioMerieux inventory for the quarter ending December 31, 2023 was $0.983B, a 33.56% increase year-over-year.
  • BioMerieux inventory for 2023 was $0.983B, a 26.59% increase from 2022.
  • BioMerieux inventory for 2022 was $0.777B, a 3.45% increase from 2021.
  • BioMerieux inventory for 2021 was $0.751B, a 21.29% increase from 2020.
BioMerieux Annual Inventory
(Millions of US $)
2023 $983
2022 $777
2021 $751
2020 $619
2019 $554
2018 $490
2017 $430
2016 $448
2015 $
BioMerieux Quarterly Inventory
(Millions of US $)
2023-12-31 $983
2022-12-31 $777
2022-06-30 $754
2021-12-31 $751
2021-06-30 $736
2020-12-31 $619
2019-12-31 $554
2019-06-30 $541
2018-12-31 $490
2018-06-30 $487
2017-12-31 $430
2017-06-30 $445
2016-12-31 $448
Sector Industry Market Cap Revenue
Medical Medical Services $12.119B $3.977B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.604B 11.61
Cencora (COR) United States $48.412B 17.85
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $22.359B 0.00
ICON (ICLR) Ireland $17.552B 15.63
Viatris (VTRS) United States $15.815B 4.87
Avantor (AVTR) United States $13.857B 20.78
Revvity (RVTY) United States $13.522B 23.49
CochLear (CHEOY) Australia $12.586B 0.00
Solventum (SOLV) United States $12.029B 0.00
Medpace Holdings (MEDP) United States $10.624B 29.93
Charles River Laboratories (CRL) United States $9.930B 19.19
HealthEquity (HQY) United States $9.139B 49.60
Doximity (DOCS) United States $8.961B 52.75
Sonic Healthcare (SKHHY) Australia $8.813B 0.00
Bausch + Lomb (BLCO) Canada $6.977B 32.47
Life Times (LTH) United States $5.046B 33.40
Organon (OGN) United States $3.835B 3.87
Sotera Health (SHC) United States $3.515B 18.80
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.968B 33.84
Concentras Parent (CON) United States $2.735B 0.00
PACS (PACS) United States $2.522B 0.00
Alignment Healthcare (ALHC) United States $2.320B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.155B 11.21
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GeneDx Holdings (WGS) United States $1.980B 0.00
Teladoc Health (TDOC) United States $1.791B 0.00
GoodRx Holdings (GDRX) United States $1.635B 42.90
Progyny (PGNY) United States $1.275B 25.81
Pediatrix Medical (MD) United States $1.267B 12.40
CareDx (CDNA) United States $1.211B 0.00
Establishment Labs Holdings (ESTA) $1.193B 0.00
AMN Healthcare Services Inc (AMN) United States $0.978B 6.62
Embecta (EMBC) United States $0.808B 5.38
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.733B 0.00
SBC Medicals (SBC) United States $0.670B 0.00
InnovAge Holding (INNV) United States $0.627B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
DocGo (DCGO) United States $0.420B 15.85
Enhabit (EHAB) United States $0.376B 32.48
COMPASS Pathways (CMPS) United Kingdom $0.304B 0.00
ModivCare (MODV) United States $0.250B 13.54
LifeMD (LFMD) United States $0.246B 0.00
Sera Prognostics (SERA) United States $0.206B 0.00
Biodesix (BDSX) United States $0.175B 0.00
Nutex Health (NUTX) United States $0.173B 0.00
Beauty Health (SKIN) United States $0.173B 0.00
MultiPlan (MPLN) United States $0.114B 0.00
Ascend Wellness Holdings (AAWH) United States $0.094B 0.00
So-Young (SY) China $0.093B 17.98
Singular Genomics Systems (OMIC) United States $0.055B 0.00
OncoCyte (OCX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.022B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00